AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review

November 2021 | 115 pages | ID: AB87A1E4537EN
GlobalData

Abstracts

AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

AstraZeneca Plc (AstraZeneca) is a biopharmaceutical company, which discovers, produces and commercializes a wide range of prescription drugs. It focuses on therapy areas such as respiratory; cardiovascular, renal and metabolic diseases; and cancer, besides autoimmune, infection and neurological diseases. The company’s product portfolio includes biologics, prescription pharmaceuticals and vaccines. AstraZeneca sells its products through wholly-owned local marketing companies, distributors and local representative offices. The company markets its products to primary care and specialty care physicians. The COVID-19 Vaccine AstraZeneca has been approved for conditional marketing or emergency use. The company operates in Europe, the Americas, Asia, Africa and Australasia. AstraZeneca is headquartered in Cambridge, Cambridgeshire, the UK.

AstraZeneca Plc Key Recent Developments

Nov 23,2021: AstraZeneca unveils The Discovery Centre (DISC) in Cambridge
Nov 18,2021: Lung Cancer Research Foundation and AstraZeneca announce research grant awards
Nov 12,2021: AstraZeneca: Year-to-date and Q3 2021 results
Nov 12,2021: Ionis' antisense therapies to be featured at the American Heart Association (AHA) Scientific Sessions 2021
Nov 11,2021: NCCN announces funding for early-stage non-small cell lung cancer projects, in collaboration with AstraZeneca

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

AstraZeneca Plc - Key Facts
AstraZeneca Plc - Key Employees
AstraZeneca Plc - Key Employee Biographies
AstraZeneca Plc - Major Products and Services
AstraZeneca Plc - History
AstraZeneca Plc - Company Statement
AstraZeneca Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Company Overview
AstraZeneca Plc - Business Description
Business Segment: Collaboration Revenue
Overview
Performance
Business Segment: Product Sales
Overview
Performance
Geographical Segment: Asia, Africa & Australasia
Target Markets
Performance
Geographical Segment: Continental Europe
Target Markets
Performance
Geographical Segment: The Americas
Target Markets
Performance
Geographical Segment: UK
Performance
R&D Overview
AstraZeneca Plc - Corporate Strategy
AstraZeneca Plc - SWOT Analysis
SWOT Analysis - Overview
AstraZeneca Plc - Strengths
AstraZeneca Plc - Weaknesses
AstraZeneca Plc - Opportunities
AstraZeneca Plc - Threats
AstraZeneca Plc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
AstraZeneca Plc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Nov 23, 2021: AstraZeneca unveils The Discovery Centre (DISC) in Cambridge
Nov 18, 2021: Lung Cancer Research Foundation and AstraZeneca announce research grant awards
Nov 12, 2021: AstraZeneca: Year-to-date and Q3 2021 results
Nov 12, 2021: Ionis' antisense therapies to be featured at the American Heart Association (AHA) Scientific Sessions 2021
Nov 11, 2021: NCCN announces funding for early-stage non-small cell lung cancer projects, in collaboration with AstraZeneca
Nov 05, 2021: AstraZeneca advances ambition to redefine care for blood cancer at ASH 2021
Nov 03, 2021: Saga Diagnostics, AstraZeneca sign dPCR assay development agreement
Nov 01, 2021: TGA recognises two more COVID-19 vaccines not registered in Australia but used widely internationally
Oct 25, 2021: AstraZeneca’s vaccine dosing ‘mistake’ led to new dosage finding in mice
Oct 20, 2021: AstraZeneca in collaboration with Rajiv Gandhi Cancer Institute announces the launch of Project Chariot to help diagnose and treat patients with Chronic Lymphocytic Leukemia (CLL)

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

AstraZeneca Plc, Key Facts
AstraZeneca Plc, Key Employees
AstraZeneca Plc, Key Employee Biographies
AstraZeneca Plc, Major Products and Services
AstraZeneca Plc, History
AstraZeneca Plc, Subsidiaries
AstraZeneca Plc, Joint Venture
AstraZeneca Plc, Key Competitors
AstraZeneca Plc, Ratios based on current share price
AstraZeneca Plc, Annual Ratios
AstraZeneca Plc, Annual Ratios (Cont...1)
AstraZeneca Plc, Annual Ratios (Cont...2)
AstraZeneca Plc, Interim Ratios
AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
AstraZeneca Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

AstraZeneca Plc, Performance Chart (2016 - 2020)
AstraZeneca Plc, Ratio Charts
AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021